Analysts' Top Healthcare Picks: Nurix Therapeutics (NRIX), Disc Medicine (IRON)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nurix Therapeutics (NRIX – Research Report), Disc Medicine (IRON – Research Report) and Silence Therapeutics (SLN – Research Report) with bullish sentiments.
Confident Investing Starts Here:
Nurix Therapeutics (NRIX)
In a report released yesterday, Derek Archila from Wells Fargo maintained a Buy rating on Nurix Therapeutics, with a price target of $25.00. The company's shares closed last Thursday at $11.96, close to its 52-week low of $11.90.
According to TipRanks.com, Archila is a 5-star analyst with an average return of 9.3% and a 50.6% success rate. Archila covers the Healthcare sector, focusing on stocks such as Zentalis Pharmaceuticals, Monte Rosa Therapeutics, and Apellis Pharmaceuticals.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Nurix Therapeutics with a $29.43 average price target, a 137.9% upside from current levels. In a report issued on June 2, Needham also maintained a Buy rating on the stock with a $27.00 price target.
Disc Medicine (IRON)
In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Disc Medicine. The company's shares closed last Thursday at $52.71.
According to TipRanks.com, Bancroft is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -9.9% and a 37.1% success rate. Bancroft covers the Healthcare sector, focusing on stocks such as Day One Biopharmaceuticals, Protagonist Therapeutics, and Whitehawk Therapeutics.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Disc Medicine with a $99.10 average price target, implying a 95.9% upside from current levels. In a report issued on June 10, Raymond James also initiated coverage with a Buy rating on the stock with a $89.00 price target.
Silence Therapeutics (SLN)
In a report released today, Myles Minter from William Blair reiterated a Buy rating on Silence Therapeutics. The company's shares closed last Thursday at $5.59, close to its 52-week low of $3.19.
According to TipRanks.com, Minter is a 4-star analyst with an average return of 6.9% and a 47.1% success rate. Minter covers the Healthcare sector, focusing on stocks such as CAMP4 Therapeutics Corporation, Neumora Therapeutics, Inc., and Entrada Therapeutics Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
a day ago
- Business Insider
Analysts Are Bullish on Top Technology Stocks: Logitech (LOGI), Adeia (ADEA)
There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Logitech (LOGI – Research Report) and Adeia (ADEA – Research Report) with bullish sentiments. Confident Investing Starts Here: Logitech (LOGI) Kepler Capital analyst Torsten Sauter maintained a Buy rating on Logitech on June 18 and set a price target of CHF88.00. The company's shares closed last Wednesday at $84.51. According to Sauter is ranked #2194 out of 9636 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Logitech with a $88.29 average price target. Adeia (ADEA) In a report released today, Scott Searle from Roth MKM initiated coverage with a Buy rating on Adeia and a price target of $26.00. The company's shares closed last Wednesday at $13.06. According to Searle is a 5-star analyst with an average return of 12.4% and a 48.7% success rate. Searle covers the Technology sector, focusing on stocks such as Sequans Communications S A, Digi International, and Universal Display. Adeia has an analyst consensus of Strong Buy, with a price target consensus of $17.33.
Business Insider
a day ago
- Business Insider
Analysts Offer Insights on Financial Companies: ANZ Group Holdings (OtherANZGF) and Suncorp Group (OtherSNMYF)
Companies in the Financial sector have received a lot of coverage today as analysts weigh in on ANZ Group Holdings (ANZGF – Research Report) and Suncorp Group (SNMYF – Research Report). Confident Investing Starts Here: ANZ Group Holdings (ANZGF) In a report released today, Richard Wiles from Morgan Stanley maintained a Hold rating on ANZ Group Holdings, with a price target of A$26.50. The company's shares closed last Friday at $18.60. According to Wiles ' ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -8.8% and a 30.4% success rate. Wiles covers the Financial sector, focusing on stocks such as National Australia Bank Limited, Bendigo & Adelaide Bank, and Bank of Queensland. Currently, the analyst consensus on ANZ Group Holdings is a Hold with an average price target of $18.18, a -2.3% downside from current levels. In a report issued on June 16, Citi also maintained a Hold rating on the stock with a A$27.50 price target. Suncorp Group (SNMYF) In a report released today, Andrei Stadnik from Morgan Stanley maintained a Buy rating on Suncorp Group, with a price target of A$25.00. The company's shares closed last Friday at $13.81. According to Stadnik is a 4-star analyst with an average return of 6.7% and a 55.3% success rate. Stadnik covers the Financial sector, focusing on stocks such as Insurance Australia Group Limited, QBE Insurance Group Limited, and Macquarie Group Limited. Suncorp Group has an analyst consensus of Moderate Buy, with a price target consensus of $14.18.
Business Insider
2 days ago
- Business Insider
Analysts Offer Insights on Materials Companies: Bluescope Steel (OtherBLSFF) and Northern Star Resources Ltd (OtherNESRF)
Analysts have been eager to weigh in on the Materials sector with new ratings on Bluescope Steel (BLSFF – Research Report) and Northern Star Resources Ltd (NESRF – Research Report). Confident Investing Starts Here: Bluescope Steel (BLSFF) In a report released today, Rohan Gallagher from Jarden maintained a Buy rating on Bluescope Steel, with a price target of A$25.30. The company's shares closed last Monday at $15.07. According to Gallagher is a 4-star analyst with an average return of 8.9% and a 56.3% success rate. Gallagher covers the Basic Materials sector, focusing on stocks such as Brickworks Ltd, James Hardie, and Sims. Currently, the analyst consensus on Bluescope Steel is a Strong Buy with an average price target of $17.76, which is a 31.1% upside from current levels. In a report issued on June 10, Jefferies also maintained a Buy rating on the stock with a A$29.00 price target. Northern Star Resources Ltd (NESRF) Jarden analyst Ben Lyons maintained a Hold rating on Northern Star Resources Ltd yesterday and set a price target of A$19.40. The company's shares closed last Wednesday at $13.86. According to Lyons is a 4-star analyst with an average return of 9.4% and a 69.3% success rate. Lyons covers the Basic Materials sector, focusing on stocks such as Sandfire Resources Limited, Mineral Resources Limited, and Pilbara Minerals. Currently, the analyst consensus on Northern Star Resources Ltd is a Moderate Buy with an average price target of $14.97, which is a 6.4% upside from current levels. In a report issued on June 16, UBS also downgraded the stock to Hold with a A$23.00 price target.
